HGH Fragment 176-191
The fat-loss tail of the HGH molecule, isolated and used alone. Goal: trigger lipolysis without GH's water retention or insulin impact.
HGH Fragment 176-191 is the part of the HGH molecule that handles fat metabolism, isolated and used alone. The point: get the fat-loss signal without GH's water retention or insulin resistance. Daily injection, fasted.
Not FDA approved. Failed obesity development.
Not formally categorized in the FDA bulks lists.
As a fragment of HGH, falls under the S2 peptide hormones category.
Not prescribed in conventional medicine.
Who it's for
- →Users wanting GH-style fat-loss signal without the bulky side effects
- →Cuts where GH-axis stacks would be too aggressive
What to expect
- Week 1
Subtle. Fasted-cardio tolerance often improves first.
- Week 4
Body comp shifts in users running it alongside a clean diet.
- Week 8
Plateau. Cycle off.
Dosing protocol
250-500 mcg sub-q, 1-2x daily, fasted, before cardio.
Stacks well with
Side effects
When NOT to use
- ⚠Active malignancy
- ⚠Pregnancy / nursing
Common mistakes
- • Expecting GLP-class results (it isn't that potent)
- • Dosing post-meal (blunts the lipolytic effect)
- • Running short cycles and quitting before adaptation
Educational only. User-specific dosing is between you and a qualified provider.